Arbutus Biopharma Corp Stock Issued During Period, Shares, Employee Stock Purchase Plans
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Arbutus Biopharma Corp stock issued during period, shares, employee stock purchase plans for fiscal 2025 was 60.49K shares, a 73.39% decline from fiscal 2024.
- Arbutus Biopharma Corp stock issued during period, shares, employee stock purchase plans for fiscal 2024 was 227.33K shares, a 21.73% decline from fiscal 2023.
- Arbutus Biopharma Corp stock issued during period, shares, employee stock purchase plans for fiscal 2023 was 290.44K shares, a 69.62% increase from fiscal 2022.
- Arbutus Biopharma Corp stock issued during period, shares, employee stock purchase plans for fiscal 2022 was 171.22K shares, a 12.79% decline from fiscal 2021.
| Period end | Stock Issued During Period, Shares, Employee Stock Purchase Plans 3 month | Stock Issued During Period, Shares, Employee Stock Purchase Plans 12 month |
|---|---|---|
| 2025-12-31 | 60.49K shares 10-K · filed 2026-03-23 | |
| 2024-12-31 | 227.33K shares 10-K · filed 2026-03-23 | |
| 2023-12-31 | 290.44K shares 10-K · filed 2025-03-27 | |
| 2022-12-31 | 171.22K shares 10-K · filed 2024-03-05 | |
| 2021-12-31 | 196.34K shares 10-K · filed 2023-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 |